vimarsana.com

Page 9 - கென்ஸ் பெர்மன் சோபோல் ஷாபிரோ ல்ப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Invites AstraZeneca (AZN) Investors to Contact Firm, Securities Fraud Case Related to Potential COVID-19 Treatment Filed

HAGENS BERMAN Invites CleanSpark (CLSK) Investors to Contact Firm, Analyst Says CleanSpark Fabricated Customers and Contracts, Calls Shares Uninvestible, Securities Fraud Case Filed

HAGENS BERMAN Invites Triterras (TRIT) Investors to Contact Firm, Analyst Calls TRIT Wirecard of Blockchain

HAGENS BERMAN Invites Triterras (TRIT) Investors to Contact Firm, Analyst Calls TRIT Wirecard of Blockchain Hagens Berman Sobol Shapiro LLP Berkeley, California, UNITED STATES SAN FRANCISCO, Jan. 19, 2021 (GLOBE NEWSWIRE) Hagens Berman urges Triterras, Inc. (NASDAQ: TRIT) investors with significant losses to submit your losses now. A securities fraud class action has been filed and certain investors may have valuable claims. Class Period: August 20, 2020 – December 16, 2020     Triterras, Inc. (TRIT) Securities Class Action: The complaint centers on the accuracy of Triterras’ and senior managements’ statements concerning the company’s dependence on- and the financial condition of- Rhodium Resources, a business controlled by Triterras CEO Srinivas Koneru.

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst s Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys Now

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Expands OrthoPediatrics (KIDS) Investigation in Light of Concurrent SEC Investigation, Analyst’s Inventory Accounting Questions, Encourages Investors to Contact Its Attorneys Now Hagens Berman Sobol Shapiro LLP Berkeley, California, UNITED STATES                                             844-916-0895 The investigation concerns whether OrthoPediatrics artificially inflated revenues and overstated inventory. In past quarters, OrthoPediatrics touted its “consistent 20% plus growth rate,” which in turn has allowed the Company to maintain a valuation at 11 times annual revenues. In doing so, OrthoPediatrics affirmed that it complied with GAAP, including by only recognizing revenue on products consigned to its distributors “when products are used in procedures.”

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Magnite, Inc (MGNI) for Possible Securities Law Violations, Encourages MGNI Investors and Persons Who May be Able to Assist to Contact its Attorneys Now

HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Investigating Magnite, Inc. (MGNI) for Possible Securities Law Violations, Encourages MGNI Investors and Persons Who May be Able to Assist to Contact its Attorneys Now Hagens Berman Sobol Shapiro LLP Berkeley, California, UNITED STATES SAN FRANCISCO, Jan. 08, 2021 (GLOBE NEWSWIRE) Hagens Berman notifies investors in Magnite, Inc. (NASDAQ: MGNI) of the firm’s investigation into possible securities law violations. Magnite investors are encouraged to submit their losses now.   The firm also encourages persons who may be able to assist the investigation to contact the firm.                                                Magnite, Inc. (MGNI) Investigation: The investigation centers on whether Magnite misled investors about the company’s financial reporting, connected TV (“CTV”) inventory, and other matters after the company was formed in 2020 through the merger of Telaria Inc.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.